1. Home
  2. CPSS vs CRBU Comparison

CPSS vs CRBU Comparison

Compare CPSS & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

N/A

Current Price

$7.57

Market Cap

186.1M

Sector

Finance

ML Signal

N/A

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

N/A

Current Price

$1.89

Market Cap

203.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPSS
CRBU
Founded
1991
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.1M
203.9M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
CPSS
CRBU
Price
$7.57
$1.89
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.75
AVG Volume (30 Days)
9.0K
1.3M
Earning Date
06-15-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.64
EPS
0.59
N/A
Revenue
$393,506,000.00
N/A
Revenue This Year
$147.09
N/A
Revenue Next Year
N/A
$10.48
P/E Ratio
$12.81
N/A
Revenue Growth
11.79
N/A
52 Week Low
$6.67
$0.66
52 Week High
$10.51
$3.53

Technical Indicators

Market Signals
Indicator
CPSS
CRBU
Relative Strength Index (RSI) 35.66 55.31
Support Level $7.47 $1.71
Resistance Level $8.60 $2.11
Average True Range (ATR) 0.26 0.15
MACD -0.07 0.00
Stochastic Oscillator 10.58 44.74

Price Performance

Historical Comparison
CPSS
CRBU

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: